Searched for
CIPLA ACQUISITIONS
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Cipla to fully acquire Inzpera HealthscienceDrug maker Cipla has acquired Inzpera Healthscience for approximately Rs 111 crore. This strategic move combines Inzpera's paediatric produ...
- Cipla stake sale plan faces hurdle as promoters differ on valuation: ReportCipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute amo...
- Torrent Pharma says it has no disclosure to make now on potential Cipla stake buy deal reportsTorrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the com...
- Cipla to acquire nutritional supplement brand Endura MassEndura and all other associated trademarks would be part of the acquisition. CHL will initiate the distribution and marketing of the Endura...
- Cipla eyes acquisitions after Covid windfallFounded in 1935 by Hamied’s grandfather in then-colonial Bombay, Cipla made its name globally by pioneering the sale of cheap, generic HIV ...
- Cipla seals Invagen and Exelan deals in USThe deal closure, that involved approvals from the US regulatory agencies, will see Cipla vault its sales from that market to around $400 m...
- Cipla's ratings unlikely to be impacted by US acquisitions: India RatingsIndia Ratings & Research today said Cipla's ratings are unlikely to be affected by the recent cash-rich acquisitions of two US-based compan...
- Nomura neutral on Cipla, target Rs 689Cipla has acquired a portfolio of largely plain vanilla oral solids where its capabilities are already well-established, and hence the acqu...
- Hetero buy will boost Cipla's US ops in next 2-3 years; hold stock @ target of Rs 755: Praful Bohra, Religare"Cipla's portfolio is of a commodity generics type; so this will definitely place it in a strong position in terms of product pipeline in t...
- Cipla to acquire Brazil's Duomed Produtos for Rs 2.6 croreThe deal has the approval of Brazilian health authority (ANVISA) and other regulatory authorities to import and distribute pharmaceutical p...
- Hamsons buys 21% stake in Okasa PharmceuticalsWhile Cipla paid Rs 29 crore for Okasa’s facility in Goa, it bought another plant, owned by Okasa Pharma, located in Satara for Rs 71.93 cr...
- Cipla rallies over 1% on acquisition plans for Rs 100 croreAt 09:35 a.m.; Cipla was trading 0.6 per cent higher at Rs 560.75. It hit a low of Rs 559 and a high of Rs 565.40 in trade today.
- Cipla acquires 60% stake in Sri Lankan firm; stock up nearly 3%As part of its global expansion, Cipla has been active in acquisitions. Last year, it completed the buyout of South African pharma firm, sa...
- Cipla buys 60% stake in Sri Lankan co for $14 million"The consideration payable for the transaction is $14 million," the filing said, adding that the proposed acquisition was subject to regula...
- Cipla completes buyout of Cipla Medpro for Rs 2,707 croreCipla on Tuesday said it has completed the buyout process of South African pharma firm Cipla Medpro for an aggregate consideration of Rs 2,...
- Cipla receives nod from South Africa authorities to acquire Cipla MedproCipla Ltd today said it has received approval from South Africa and Botswana for the $ 512 million takeover offer to acquire Cipla Medpro
- Cipla set to buy 51% of S Africa's Cipla Medpro for about $220 millionCipla said on Wednesday it will buy 51% of Cipla Medpro for about $220 million, valuing the beleaguered South African company at about $440...
Load More
